- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
FDA AND FBI MAKE ARREST IN TAMPERING INCIDENT IN THE ODESSA/MIDLAND TEXAS AREA
er
To: FDA-Wide
Subject: Definition of Scope of Products to be Consolidated
MEMORANDUM
To: All FDA Staff
From: Murray M. Lumpkin, M.D.
Theresa M. Mullin, Ph.D.
Co-chairs
CBER-CDER Product Consolidation Working Group
Re: Definition of Scope of Products to be Consolidated
on
For Immediate Release
October 22, 2002
Contact: Blain Rethmeier/Nick Mutton
(202) 225-5074
GAO's Survey Finds Anthrax Vaccine Program Hurts Retention Click here for The GAO report
Witnesses testifying before the Senate Health, Education, Labor and Pensions Committee expressed concern that the Bush administration regulation extending CHIP coverage to fetuses might exclude delivery and other critical prenatal care. Sen. Jeff Bingaman Sen. Jon S. Corzine Sen.
se
NATIONAL INSTITUTES OF HEALTH
National Human
Genome Research Institute
FOR IMMEDIATE RELEASE
Wednesday, October 23, 2002
Contact:
Geoff Spencer
(301) 402-0911
Funding for Global Protein Database Will Create One Reliable Resource
/index.php?option=com_iwpfile&file=/dir_01/he2002_2718.pdf
it
For Release: October 23, 2002
New Jersey Laboratory Charged with Providing False Test Results for Bogus Anthrax Test Kit
Defendants Banned From Testing to Detect the Presence of Biological or Chemical Warfare Agents
